Anavex Life Sciences
AVXL
46 hedge funds and large institutions have $23.4M invested in Anavex Life Sciences in 2016 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 12 closing their positions.
141% more capital invested
Capital invested by funds: $9.71M → $23.4M (+$13.7M)
58% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 12
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
18% more funds holding
Funds holding: 39 → 46 (+7)
26% less call options, than puts
Call options by funds: $851K | Put options by funds: $1.15M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.08M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.37M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$796K |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$614K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$486K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$564K |
| 2 |
Millennium Management
New York
|
-$305K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$258K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$250K |
| 5 |
HCM
Highbridge Capital Management
New York
|
-$248K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Squarepoint
New York
| – | -$107K | -21,900 | Closed |
|
52
Balyasny Asset Management
Chicago,
Illinois
| – | -$98K | -20,050 | Closed |
|
53
Verition Fund Management
Greenwich,
Connecticut
| – | -$81K | -16,478 | Closed |
|
54
SG Americas Securities
New York
| – | -$62K | -12,700 | Closed |
|
|
JG
55
Jefferies Group
New York
| – | -$60K | -12,300 | Closed |
|
56
Jane Street
New York
| – | -$49K | -10,047 | Closed |
|
57
Simplex Trading
Chicago,
Illinois
| – | -$5.61K | -1,162 | -99% |
|
|
NFG
58
Next Financial Group
Houston,
Texas
| – | -$1K | -250 | Closed |
|
AVXL Hedge Fund Activity: Q2 2016 in Review
46 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q2 2016, worth a combined $23.4M — up 141% from $9.71M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new AVXL positions and 12 closed out — a net gain of 7 holders — while 11 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $4.08M. The largest seller was Susquehanna International Group, cutting an estimated $564K.
- 46 institutional investors held Anavex Life Sciences (AVXL) as of Q2 2016, up from 39 in Q1 2016.
- Funds reported $23.4M of Anavex Life Sciences stock for Q2 2016, up 141% quarter-over-quarter.
- 19 funds opened new Anavex Life Sciences positions in Q2 2016 and 12 closed out, a net change of +7 holders.
- The largest Anavex Life Sciences buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $4.08M added.
- The largest Anavex Life Sciences seller in Q2 2016 was Susquehanna International Group, an estimated $564K sold.
Based on aggregated 13F filings for Q2 2016.